Plant ID: NPO19015
Plant Latin Name: Begonia glabra
Taxonomy Genus: Begonia
Taxonomy Family: Begoniaceae
NCBI TaxonomyDB:
62974
Plant-of-the-World-Online:
104759-1
Brazil; Jamaica; Belize; Honduras; Peru; Suriname; Cuba; Venezuela; Mexico; Costa Rica; Trinidad and Tobago; Guatemala; China; Colombia; French Guiana; Bolivia; Nicaragua; Ecuador
ATP1A1; | |
RECQL; | |
RORC; | |
STAT3; TP53; | |
SLCO4C1; SLCO1B1; | |
RAB9A; MAPT; PAX8; NPC1; LMNA; |
Cytochrome P450 Enzymes: | CYP3A4; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | RECQL | ATP-dependent DNA helicase Q1 | P46063 | CHEMBL1293236 |
Hydrolase | ATP1A1 | Sodium/potassium-transporting ATPase alpha-1 chain | P05023 | CHEMBL1807 |
Nuclear hormone receptor subfamily 1 group F | RORC | Nuclear receptor ROR-gamma | P51449 | CHEMBL1741186 |
SLC superfamily of solute carriers | SLCO4C1 | Solute carrier organic anion transporter family member 4C1 | Q6ZQN7 | CHEMBL2073690 |
SLC superfamily of solute carriers | SLCO1B1 | Solute carrier organic anion transporter family member 1B1 | Q9Y6L6 | CHEMBL1697668 |
Transcription Factor | STAT3 | Signal transducer and activator of transcription 3 | P40763 | CHEMBL4026 |
Transcription Factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Unclassified | RAB9A | Ras-related protein Rab-9A | P51151 | CHEMBL1293294 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Unclassified | PAX8 | Paired box protein Pax-8 | Q06710 | CHEMBL2362980 |
Unclassified | NPC1 | Niemann-Pick C1 protein | O15118 | CHEMBL1293277 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0005496; steroid binding | 2.540E-07 | 5.530E-03 | ATP1A1, CYP3A4, NPC1, RORC |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09160 Human Diseases | 09167 Infectious diseases | hsa05162 | Measles | 3.564E-05 | 2.744E-03 | STAT3, RAB9A, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05216 | Thyroid cancer | 9.070E-05 | 3.492E-03 | PAX8, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05212 | Pancreatic cancer | 4.745E-04 | 8.454E-03 | STAT3, TP53 |
09150 Organismal Systems | 09152 Endocrine system | hsa04918 | Thyroid hormone synthesis | 5.490E-04 | 8.454E-03 | PAX8, ATP1A1 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 5.490E-04 | 8.454E-03 | ATP1A1, CYP3A4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
J00-J99: Diseases of the respiratory system | Chronic obstructive pulmonary disease | J40-J44, J47 | ATP1A1; |
C00-D49: Neoplasms | Cancer | C00-C96 | STAT3; ATP1A1; TP53; |
E00-E89: Endocrine, nutritional and metabolic diseases | Atrial fibrillation | E78, I48 | ATP1A1; |
C00-D49: Neoplasms | Multiple myeloma | C90 | STAT3; |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified | Anesthesia | R20.0 | ATP1A1; |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified | Hyperhidrosis | R61 | ATP1A1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Anxiety disorder | F32, F40-F42 | CYP3A4; |
A00-B99: Certain infectious and parasitic diseases | Fungal infections | B35-B49 | RAB9A; |
C00-D49: Neoplasms | Colorectal cancer | C18-C21 | TP53; |
I00-I99: Diseases of the circulatory system | Congestive heart failure | I50 | ATP1A1; |
C00-D49: Neoplasms | Hepatocellular carcinoma | C22.0 | STAT3; |
NA: NA | Arrhythmias | NA | ATP1A1; |
C00-D49: Neoplasms | Late-stage solid tumors | C00-C75, C7A, C7B, D10-D36, D3A | TP53; |
H60-H95: Diseases of the ear and mastoid process | Hearing disorder | H90.5 | TP53; |
C00-D49: Neoplasms | Head and neck cancer | C07-C14, C32-C33 | TP53; |
I00-I99: Diseases of the circulatory system | Heart failure | I50 | ATP1A1; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | STAT3; TP53; |
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | MAPT; |
G00-G99: Diseases of the nervous system G00-G99 | Central nervous system disease | G00-G99 | MAPT; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Toxicity | T36-T50, T51-T65 | TP53; |
I00-I99: Diseases of the circulatory system | Renal artery disease | I70.1 | TP53; |
C00-D49: Neoplasms | Acute myeloid leukemia | C92.0 | TP53; |
G00-G99: Diseases of the nervous system G00-G99 | Neurodegenerative disease | G30-G32 | MAPT; |
C00-D49: Neoplasms | Oral cavity cancer | C00-C08 | TP53; |
C00-D49: Neoplasms | Hematological malignancies | C81-C86 | TP53; |
L00-L99: Diseases of the skin and subcutaneous tissue | Psoriasis | L40 | STAT3; |
NA: NA | Congestive cardiac insufficiency | NA | ATP1A1; |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | ATP1A1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Cognitive disorders | F01-F07, F04, F05, R41.3 | MAPT; |